Skip to main content
logo
Shield Therapeutics plc (AIM:STX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
4.910
+0.010 (0.20%)
Aug 21, 2026, 3:59 PM GMT

Shield Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5210521521896
Market Cap Growth
-25.65%395.31%-59.70%186.53%-80.96%28.62%
Enterprise Value
6411631461673
Last Close Price
0.050.100.030.070.070.43

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-113.42113.42113.42113.42113.42
PS Ratio
1.172.830.825.104.0163.24
PB Ratio
-4.04-9.34-20.074.443.372.36
P/TBV Ratio
---4.824.154.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.463.151.194.503.4848.36

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-2.00-2.00-20.021.351.040.00
Net Debt / Equity Ratio
-1.23-1.23-15.070.420.52-0.29
Net Debt / EBITDA Ratio
-1.88-1.88-0.89-0.20-0.110.64
Net Debt / FCF Ratio
-5.44-5.44-2.92-0.17-0.150.64
Asset Turnover
0.810.810.610.350.140.04
Inventory Turnover
3.593.593.893.651.630.65
Quick Ratio
0.670.670.901.830.623.73
Current Ratio
0.900.901.162.280.954.64
Return on Equity (ROE)
---396.36%-308.60%-179.19%-55.46%
Return on Assets (ROA)
-10.24%-10.24%-26.90%-51.93%-49.37%-32.97%
Return on Capital Employed (ROCE)
-66.70%-66.70%-92.00%-89.40%-229.50%-49.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.07%-12.54%-102.83%-49.88%-225.97%-20.48%
FCF Yield
1.92%-2.42%-25.74%-55.98%-102.82%-19.40%
Buyback Yield / Dilution
-33.81%-33.81%-8.33%-209.85%-14.08%-74.36%